Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors

BACKGROUND: Patients with cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti-SARS-CoV-2 immunity in cancer patients has not been proposed. METHODS: We employed machine lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Konnova, Angelina, De Winter, Fien H. R., Gupta, Akshita, Verbruggen, Lise, Hotterbeekx, An, Berkell, Matilda, Teuwen, Laure-Anne, Vanhoutte, Greetje, Peeters, Bart, Raats, Silke, der Massen, Isolde Van, De Keersmaecker, Sven, Debie, Yana, Huizing, Manon, Pannus, Pieter, Neven, Kristof Y., Ariën, Kevin K., Martens, Geert A., Bulcke, Marc Van Den, Roelant, Ella, Desombere, Isabelle, Anguille, Sébastien, Berneman, Zwi, Goossens, Maria E., Goossens, Herman, Malhotra-Kumar, Surbhi, Tacconelli, Evelina, Vandamme, Timon, Peeters, Marc, van Dam, Peter, Kumar-Singh, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813584/
https://www.ncbi.nlm.nih.gov/pubmed/36618384
http://dx.doi.org/10.3389/fimmu.2022.1062136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813584/
https://www.ncbi.nlm.nih.gov/pubmed/36618384
http://dx.doi.org/10.3389/fimmu.2022.1062136

Ejemplares similares